L'Alma Mater Studiorum - Università di Bologna è un'università italiana statale. Attiva dall'XI secolo, è considerata da molteplici fonti la più antica università del mondo tuttora in funzione.

During the past decade, University of Bologna conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 7 clinical trials were completed, i.e. on average, 17.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 6 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Bologna" #1 sponsor was "University of Bologna" with 11 trials, followed by "Celgene" with 4 trials sponsored, "Actelion" with 2 trials sponsored, "Thomas Jefferson University" with 2 trials sponsored and "United Therapeutics" with 2 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Bologna" #1 collaborator was "University of Bologna" with 4 trials as a collaborator, "Federico II University" with 2 trials as a collaborator, "Universiteit Antwerpen" with 2 trials as a collaborator, "Albany Medical College" with 1 trials as a collaborator and "Associazione Per La Ricerca Cardiologica (Roma)" with 1 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "University of Bologna" are "Multiple Myeloma" (3 trials), "Neck Pain" (3 trials), "Acute Coronary Syndrome" (2 trials), "Acute Myeloid Leukemia" (2 trials) and "Coronary Disease" (2 trials). Many other conditions were trialed in "University of Bologna" in a lesser frequency.

Most popular intervention types in "University of Bologna" are "Drug" (23 trials), "Other" (14 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dexamethasone" (3 trials), "Bortezomib" (2 trials), "Cyclophosphamide" (2 trials) and "Cytarabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Bologna" are 54 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Bologna". undefined are not yet recruiting, 15 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in University of Bologna, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Bologna, 7 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".

University of Bologna has several departments that took part in Clinical trials: "Radiation Oncology Center, Department of Experimental, Diagnostic and Speciality Medicine- DIMES, University of Bologna, S.Orsola-Malpighi Hospital" - 12 trials, "Department of Medical and Surgical Sciences University of Bologna" - 5 trials, "Nephrology Dialysis and Renal Transplantation Unit, S.Orsola University Hospital" - 3 trials, "School of Dentistry - University of Bologna" - 3 trials, "Heart Failure and Heart Transplant Unit, University of Bologna" - 2 trials